PHIBRO ANIMAL HEALTH CORP

PAHC · XNAS

CIK 1069899fmd_1369R9FGB7EQYE7SJ0QXRQ21RPManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2011 to Sep 30, 2026, 58 periods

Income Statement · Annual · Millions · USD
Line item	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Total revenues	764	820	828	800	833	942	978	1,018	1,296	1,518
Cost of revenue	516	553	563	543	562	657	680	705	896	1,006
Net interest income	(15)	(12)	(12)	(13)	(13)	(12)	(15)	–	–	–
Gross profit	248	267	265	257	271	285	298	313	400	513
Research and development	9	10	12	14	18	21	24	29	24	25
Selling, general and administrative	150	168	181	188	197	206	226	260	289	318
Operating income	98	99	83	69	75	79	72	53	110	194
Interest expense	17	14	14	15	14	13	19	23	37	46
Interest and investment income	2	2	2	2	1	1	3	4	3	2
Other non-operating income (expense)	–	–	–	–	–	–	–	–	–	–
Income before taxes	81	88	72	56	66	72	54	11	68	137
Income tax expense	16	23	17	22	12	23	21	9	20	38
Net income from continuing operations	65	65	55	34	54	49	33	2	48	100
Net income	65	65	55	34	54	49	33	2	48	100
Net income to common shareholders	–	–	–	34	54	49	33	2	48	100